News Daily News Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV Events Marcus A. Banks July 25, 2019
News Daily News Clopidogrel-Aspirin in Minor Stroke/TIA of Maximum Benefit in First 21 Days Todd Neale July 09, 2019
News Daily News Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI? Michael O'Riordan July 03, 2019
News Daily News High Levels of Lp(a) Linked to Increased Ischemic Stroke Risk Michael O'Riordan July 01, 2019
News Daily News Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues Todd Neale June 26, 2019
News Conference News EAS 2019 Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality Michael O'Riordan June 05, 2019
News Conference News EuroPCR 2019 ROBOT-ACS: Real-World Data Reiterate Ticagrelor’s Safety L.A. McKeown May 31, 2019
News Conference News EAS 2019 Clear CVD Risk Reduction With PCSK9 Inhibitors, but No Mortality Effect: Meta-analysis Michael O'Riordan May 28, 2019
News Daily News Higher Risk of Intracranial Hemorrhage With Aspirin in Primary Prevention Michael O'Riordan May 20, 2019
News Conference News HRS 2019 Even in the DOAC Era, Women Less Likely Than Men to Receive Anticoagulation for A-fib Todd Neale May 17, 2019
News Daily News Bariatric Surgery Linked to Survival Advantage After MI and CVA Michael O'Riordan May 13, 2019
News Daily News Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure Michael O'Riordan May 06, 2019
News Daily News Help, Not Harm: Omega-6 PUFAs Linked With Lower Risk of CVD Events Michael O'Riordan April 18, 2019
News Daily News Most STEMI Patients Head to ICU After PCI, but Not All Need to Go Michael O'Riordan April 15, 2019
News Daily News Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor Michael O'Riordan April 12, 2019
News Daily News New Genetic Evidence Shows Alcoholic Drinks Don’t Cut Stroke Risk Yael L. Maxwell April 09, 2019
News Conference News ACC 2019 New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin Shelley Wood March 26, 2019